Structure-activity relationships in toll-like receptor-2 agonistic diacylthioglycerol lipopeptides.
about
Targeting Toll-like receptors with small molecule agentsIdentification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen.Human Toll-like receptor 8-selective agonistic activities in 1-alkyl-1H-benzimidazol-2-aminesDeterminants of activity at human Toll-like receptors 7 and 8: quantitative structure-activity relationship (QSAR) of diverse heterocyclic scaffolds.Structure-activity relationships in human Toll-like receptor 8-active 2,3-diamino-furo[2,3-c]pyridines.A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors.Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide.Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity.Toll-like receptor-8 agonistic activities in C2, C4, and C8 modified thiazolo[4,5-c]quinolinesDesign and development of stable, water-soluble, human Toll-like receptor 2 specific monoacyl lipopeptides as candidate vaccine adjuvants.TLR2 & Co: a critical analysis of the complex interactions between TLR2 and coreceptors.Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impact.Strategies for designing synthetic immune agonists.Controlling the origins of inflammation with a photoactive lipopeptide immunopotentiator.Structure-activity relationships in toll-like receptor 2-agonists leading to simplified monoacyl lipopeptides.Potent adjuvantic activity of a CCR1-agonistic bis-quinoline.Toll-like receptor (TLR)-7 and -8 modulatory activities of dimeric imidazoquinolines.Light Guided In-vivo Activation of Innate Immune Cells with Photocaged TLR 2/6 Agonist.Toward self-adjuvanting subunit vaccines: model peptide and protein antigens incorporating covalently bound toll-like receptor-7 agonistic imidazoquinolines.Structure-activity relationships in human Toll-like receptor 2-specific monoacyl lipopeptides.Exquisite selectivity for human toll-like receptor 8 in substituted furo[2,3-c]quinolines.Structure-activity relationships in nucleotide oligomerization domain 1 (Nod1) agonistic γ-glutamyldiaminopimelic acid derivatives.Peptide Lipidation - A Synthetic Strategy to Afford Peptide Based Therapeutics.Glycerol as Precursor of Organoselanyl and Organotellanyl Alkynes.Syntheses of Human TLR8-Specific Small-Molecule Agonists.
P2860
Q26992220-33EC7349-523C-4439-B0A3-4B5FC43F27F9Q30388683-3B38DA01-865C-49E8-9897-09B07F1D8CCDQ34164851-43B9667A-0D05-4201-B67F-215F9CB083AFQ34313816-E4C7E937-0A4C-446F-8074-A157F375E203Q34394100-127BFB01-653D-47CD-9668-6604407CBC73Q35166960-34306F99-33DF-4E26-A340-493E586D3ABDQ35886752-1E4FED03-5BAD-497A-BBDA-A9E53315571DQ36147897-278A6355-9856-4E59-B809-74EFF1BD18A6Q36625137-655F803A-9164-43B7-B3F7-7755E5463431Q37352073-BE530460-0D04-4F54-8A0F-DFA30CE23ED2Q38132733-F12AA282-2733-4AC9-88D6-E8BBEF898BE4Q38279548-95EC250D-DCEC-40FC-B30A-C0526F01281FQ38841677-B430B39A-4040-4F13-9676-0E9ADC7C2577Q39026309-8F485B09-7623-484F-971F-CB59CD47490CQ39539750-AD49E47D-68E0-4E2C-A83F-5DDA0FE455B4Q40077881-3484C865-0425-4E0B-B362-D6628C25D297Q40998064-B3004225-AC02-4BF9-AAD4-314FE1450E79Q41388766-DC6B90D8-8502-4BF1-9BFE-ABB162072F16Q42021841-2242959B-7B02-4E4C-BC82-D34CF06E8A5DQ42050375-C8D4405F-2A25-4401-B105-CBFE318AF7BFQ42096062-17AD255F-80A6-47DE-B246-8284203ED34DQ42716723-B29594CC-E364-400A-B7F1-D0ABA13D0E35Q47590580-344846D8-5365-452C-96F7-9F7439238E51Q50206650-A7FE87BF-25BC-4793-877C-85E760FD4EE3Q51415073-E24E27AD-539F-4483-81D6-E085A8DBAF9C
P2860
Structure-activity relationships in toll-like receptor-2 agonistic diacylthioglycerol lipopeptides.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Structure-activity relationshi ...... acylthioglycerol lipopeptides.
@en
Structure-activity relationshi ...... acylthioglycerol lipopeptides.
@nl
type
label
Structure-activity relationshi ...... acylthioglycerol lipopeptides.
@en
Structure-activity relationshi ...... acylthioglycerol lipopeptides.
@nl
prefLabel
Structure-activity relationshi ...... acylthioglycerol lipopeptides.
@en
Structure-activity relationshi ...... acylthioglycerol lipopeptides.
@nl
P2093
P2860
P356
P1476
Structure-activity relationshi ...... acylthioglycerol lipopeptides.
@en
P2093
Apurba Datta
Hemamali J Warshakoon
Matthew R Kimbrell
Michael W Amolins
Rehman Ukani
Subbalakshmi S Malladi
Sunil A David
P2860
P304
P356
10.1021/JM901839G
P407
P577
2010-04-01T00:00:00Z